Back to Search Start Over

Cerebrolysin: spectrum of activity and research data. Part 2

Authors :
N. D. Bukreeva
E. A. Rakityanskaya
Source :
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева, Vol 0, Iss 2, Pp 41-52 (2018)
Publication Year :
2018
Publisher :
Federal State Budget Scientific Institution National Medical Research Center for Psychiatry and Neurology n.a. V.M. Bekhterev Ministry of Health of the Russian Federation, 2018.

Abstract

The results of analysis of experimental and clinical studies have shown that Cerebrolysin application is safe and effective therapy for many neurological disorders ranging from stroke and ending Alzheimer’s disease. The primary effect of the medicine is associated with the influence of Cerebrolysin on certain areas of the hippocampus and their function. The medicine has a unique organ-multimodal action on the brain, it is capable of metabolic regulation, neuroprotection, functional neuromodulation and neurotrophic activity, detected in numerous experimental studies. The clinical efficacy of the medicine is confirmed by clinical trials performed based on GCP requirements.

Details

Language :
Russian
ISSN :
23137053 and 2713055X
Issue :
2
Database :
Directory of Open Access Journals
Journal :
Обозрение психиатрии и медицинской психологии имени В.М. Бехтерева
Publication Type :
Academic Journal
Accession number :
edsdoj.93f710c0d25844a38ddd1bb2f2ba4339
Document Type :
article